Marina Biotech Announces a License Agreement to Deliver a Genome Editing Technology
Marina Biotech has signed a license agreement covering the company's SMARTICLES and DiLA2 platforms for the delivery of an undisclosed genome editing technology.
The agreement is…
Read More...
Read More...